Epstein-Barr-virus-induced interstitial lung disease

Current Opinion in Pulmonary Medicine

Volumn 11, Issue 5, 2005, Pages 456-460

  Marzouk, Kamel ^a,b   Corate, Lalaine ^a   Saleh, Samer ^a   Sharma, Om P ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

AIDS; Epstein Barr virus; Idiopathic pulmonary fibrosis; Interstitial lung disease; Langerhans cell histiocytosis; Lymphocytic interstitial pneumonia; Sarcoidosis

Indexed keywords

ACICLOVIR; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; LATENT MEMBRANE PROTEIN 1; STEROID; VIRUS ANTIGEN; VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CANCER INCIDENCE; CLINICAL FEATURE; EPITHELIUM CELL; EPSTEIN BARR VIRUS; HISTIOCYTOSIS X; HUMAN; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LABORATORY TEST; LUNG ALVEOLUS CELL; LUNG BIOPSY; LUNG CANCER; LUNG FIBROSIS; PHYSICAL EXAMINATION; PROGNOSIS; REVIEW; SARCOIDOSIS; SPLENOMEGALY; VIRUS EXPRESSION; VIRUS INFECTION; VIRUS REPLICATION;

EID: 24744468034     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/01.mcp.0000176678.38539.9a     Document Type: Review

References (23)

1. Geist LJ, Hunninghake GW. Potential role of viruses in the pathogenesis of pulmonary fibrosis. Chest 1993; 103:119S-120S.
2. Lung ML, Lam WK, So SY, et al. Evidence that respiratory tract is major reservoir for Epstein-Barr virus. Lancet 1985; 1:889-892.
3. Britton S, Andersson-Anvret M, Gergely P, et al. Epstein-Barr-virus immunity and tissue distribution in a fatal case of infectious mononucleosis. N Engl J Med 1978; 298:89-92.
4. Ankermann T, Claviez A, Wagner HJ, et al. Chronic interstitial lung disease with lung fibrosis in a girl: uncommon sequelae of Epstein-Barr virus infection. Pediatr Pulmonol 2003; 35:234-238.
5. Sriskandan S, Labrecque LG, Schofield J. Diffuse pneumonia associated with infectious mononucleosis: detection of Epstein-Barr virus in lung tissue by in situ hybridization. Clin Infect Dis 1996; 22:578-579.
6. Myers JL, Peiper SC, Katzenstein AL. Pulmonary involvement in infectious mononucleosis: histopathologic features and detection of Epstein-Barr virus-related DNA sequences. Mod Pathol 1989; 2:444-448.
7. Lung ML, Lam WK, So SY, et al. Evidence that respiratory tract is major reservoir for Epstein-Barr virus. Lancet 1985; 1:889-892.
8. Egan JJ, James PS, Hasleton PS, et al. Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis. Thorax 1995; 50:1234-1239.
9. Stewart JP, Egan JJ, Ross AJ, et al. The detection of Epstein-Barr virus DNA in lung tissue from patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1999; 159:1336-1341.
10. Wangoo A, Shaw RJ, Diss TC, et al. Cryptogenic fibrosing alveolitis: lack of association with Epstein-Barr virus infection. Thorax 1997; 52:888-891.
11. Tsukamoto K, Hayakawa H, Sato A, et al. Epstein-Barr virus latent membrane protein-1 is involved in disease progression in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 157:A495.
12. Liebowitz D, Wang D, Kieff E. Orientation and patching the latent infection membrane protein encoded by Epstein-Barr virus. J Virol 1986; 58:233-237.
13. Dawson CW, Rickinson AB, Young LS. Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature 1990; 344:777-780.
14. Tsukamoto K, Hayakawa H, Sato A, et al. Involvement of Epstein-Barr virus latent membrane protein 1 in disease progression in patients with idiopathic pulmonary fibrosis. Thorax 2000; 55:958-961.
15. Kramer MR, Saldana MJ, Ramos M, Pitchenik AE. High titers of Epstein-Barr virus antibodies in adult patients with lymphocytic interstitial pneumonitis associated with AIDS. Respir Med 1992; 86:49-52.
16. Shimakage M, Sasagawa T, Kimura M, et al. Sakamoto:Expression of Epstein-Barr virus in Langerhans' cell histiocytosis. H. Hum Pathol 2004; 35:862-868.
17. Yonemaru M, Kasuga I, Kusumoto H, et al. Elevation of antibodies to cytomegalovirus and other herpes viruses in pulmonary fibrosis. Eur Respir J 1997; 10:2040-2045.
18. Hayakawa H, Shirai M, Uchiyama H, et al. Lack of evidence for a role of Epstein-Barr virus in the increase of lung cancer in idiopathic pulmonary fibrosis. Respir Med 2003; 97:281-284.
19. Katz BZ, Berkmann AB, Shapiro ED. Serologic evidence of active Epstein-Barr virus infection in Epstein-Barr virus associated lymphoproliferative disorders of children with acquired immunodeficiency syndrome. J Pediatr 1992; 120:228-232.
20. Osika E, Muller MH, Boccon-Gibod L, et al. Idiopathic pulmonary fibrosis in infants. Pediatr Pulmonol 1997; 23:49-54.
21. Purtilo DT, Tatsumi E, Manolov G. Epstein-Barr virus as an etiological agent in the pathogenesis of lymphoproliferative and aproliferative diseases in immune deficient patients. Int Rev Exp Pathol 1985; 27:112-183.
22. Pfleger A, Eber E, Popper H, Zach MS. Chronic interstitial lung disease due to Epstein-Barr virus infection in two infants. Eur Respir J 2000; 15:803-806.
23. Redding GJ, Fan L. Idiopathic pulmonary fibrosis and lymphocytic interstitial pneumonia. In: Taussig LM, Landau LI, editors. Pediatric respiratory medicine. St. Louis: Mosby; 1999. p 794-798.